Type
Internal restructuring
Country
France
Region
Bassin Parisien; Haute-Normandie; Eure
Location of affected unit(s)
Évreux
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

1,184 jobs
Number of planned job losses
Job loss
Announcement Date
5 February 2009
Employment effect (start)
1 January 2010
Foreseen end date
31 December 2012

Description

GlaxoSmithKline, a global pharmaceutical group, has announced its plans to cut 1,184 of its 2,000 jobs at its plant in Evreux, Haute-Normandie in northern France.

In February 2009, the group has announced that it will make 798 employees redundant at its plant in Evreux, Haute-Normandie. The redundancies represent 40% of the workforce (2000 approx). 96 of the redundancies will come from the research unit, which is to be closed.

In October 2009, the CEO has announced the cuts of 434 additional jobs. This is part of a global cost-cutting programme. The group announced that it intended to save €1.9 million between now and 2011.


Sources

Citation

Eurofound (2009), Glaxo Smith Kline, Internal restructuring in France, factsheet number 68529, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68529.